Ashok P. Pai

Hematology | Oncology

3701 Broadway
3rd Floor
Oakland, CA 94611

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Weak Evidence, Rare Eligibility, and Complex Care Coordination Limit Application of Structured Surveillance for Subsegmental Pulmonary Embolism.

Weak Evidence, Rare Eligibility, and Complex Care Coordination Limit Application of Structured Surveillance for Subsegmental Pulmonary Embolism.

Journal: Annals of emergency medicine

Published: September 03, 2025

Corrigendum to 'Preemptive anticoagulation during antenatal pulmonary embolism diagnostics in a community setting: retrospective cohort study': [Research and Practice in Thrombosis and Haemostasis Volume 9, Issue 1, January 2025, 102695].

Corrigendum to 'Preemptive anticoagulation during antenatal pulmonary embolism diagnostics in a community setting: retrospective cohort study': [Research and Practice in Thrombosis and Haemostasis Volume 9, Issue 1, January 2025, 102695].

Journal: Research and practice in thrombosis and haemostasis

Published: June 16, 2025

IgA or IgM MGUS less than 1.0 g/dL is at low risk of progression to neoplasm.

IgA or IgM MGUS less than 1.0 g/dL is at low risk of progression to neoplasm.

Journal: Blood neoplasia

Published: December 02, 2024

Decision Support Intervention and Anticoagulation for Emergency Department Atrial Fibrillation: The O'CAFÉ Stepped-Wedge Cluster Randomized Clinical Trial.

Decision Support Intervention and Anticoagulation for Emergency Department Atrial Fibrillation: The O'CAFÉ Stepped-Wedge Cluster Randomized Clinical Trial.

Journal: JAMA network open

Published: November 06, 2024

Preemptive anticoagulation during antenatal pulmonary embolism diagnostics in a community setting: retrospective cohort study.

Preemptive anticoagulation during antenatal pulmonary embolism diagnostics in a community setting: retrospective cohort study.

Journal: Research and practice in thrombosis and haemostasis

Published: October 14, 2024

American Society of Hematology living guidelines on use of anticoagulation for thromboprophylaxis for patients with COVID-19: executive summary.

American Society of Hematology living guidelines on use of anticoagulation for thromboprophylaxis for patients with COVID-19: executive summary.

Journal: Blood advances

Published: August 02, 2024

Expanding outpatient management of low-risk pulmonary embolism to the pregnant population: a case series.

Expanding outpatient management of low-risk pulmonary embolism to the pregnant population: a case series.

Journal: European heart journal. Case reports

Published: December 22, 2023

Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19.

Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19.

Journal: JAMA network open

Published: March 13, 2023

Risk of VTE in Nonrespiratory and Respiratory Presentations of COVID-19 in Critically Ill Patients.

Risk of VTE in Nonrespiratory and Respiratory Presentations of COVID-19 in Critically Ill Patients.

Journal: Chest

Published: December 17, 2022

Risk of posthospital venous thromboembolism in patients with COVID-19 varies by SARS-CoV-2 period and vaccination status.

Risk of posthospital venous thromboembolism in patients with COVID-19 varies by SARS-CoV-2 period and vaccination status.

Journal: Blood advances

Published: September 19, 2022

Adding a Clinical Hemophilia Pharmacist to the Hemophilia Comprehensive Care Model Improves Health Care-Related Outcomes and Drug-Related Costs in an Integrated Health Care System.

Adding a Clinical Hemophilia Pharmacist to the Hemophilia Comprehensive Care Model Improves Health Care-Related Outcomes and Drug-Related Costs in an Integrated Health Care System.

Journal: The Permanente journal

Published: August 22, 2022

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients.

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients.

Journal: Blood advances

Published: April 25, 2022

Showing 1-12 of 25

Last Updated: 09/26/2026